Photo: isbtweb.org
Mar 3, 2026, 14:21
Webinar on CAR-T Cells – Heterogeneity, Quality Control, and Adverse Events – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“ISBT Webinar: Let’s talk CAR-T cells – heterogeneity, quality control and adverse events.
4 March 2026 | 17:00–18:00 CET
Join Oulghazi Salim for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.
Ideal for scientists, transfusion professionals, MDs, and MSc/PhD students.
Register now and be part of the conversation”
Stay updated with Hemostasis Today.
-
Mar 3, 2026, 16:21Tareq Abadl: Why HIV Antibodies Stay Positive Even When Viral Load Is Zero?
-
Mar 3, 2026, 16:12Mark Crowther Congratulates Mary Cushman on Her Appointment as ISTH President
-
Mar 3, 2026, 15:42Cheng-Hock Toh։ The Unrecognised Central Role of Hematology in Healthcare Design
-
Mar 3, 2026, 15:38Ahmed Koriesh: MeVO Thrombectomy – How The Evidence Evolved
-
Mar 3, 2026, 15:34Tareq Abadl: Why Is Measuring Schistocytes Critical in a Thrombocytopenic Patient?
-
Mar 3, 2026, 15:32Sanna Rijpma: The Evaluation of The Thrombin Generation Capacity in Detecting Coagulation Factor Deficiency
-
Mar 3, 2026, 15:28Mary Cushman Elected ISTH President for 2028–2030
-
Mar 3, 2026, 15:20Brian A Beh: 5 Strategies to Assist and Maintain Motivation During Stroke Rehabilitation
-
Mar 3, 2026, 15:16Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH